ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CD146 Antibody [B-T46] - BSA and Azide free (A342151)

Mouse monoclonal [B-T46] IVD antibody to CD146 for WB and Flow Cytometry.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 10-14 business days.
Name
Anti-CD146 Antibody [B-T46] - BSA and Azide free
Description
Mouse monoclonal [B-T46] IVD antibody to CD146.
Specificity
This product recognizesboth recombinant and natural human CD146.
Applications
WB, Flow Cytometry
Reactivity
Human
Immunogen
Recombinant human CD146.
Host
Mouse
Clonality
Monoclonal
Clone ID
B-T46
Myeloma
Source: Myeloma X63/AG.8653 x Balb/c node cells
Isotype
Mouse IgG1 Kappa light chain
Conjugate

Unconjugated

Concentration
1.0 mg/mL (+/- 10 %)
Product Form
Liquid
Formulation
Phosphate-buffered saline. Sterile-filtered through 0.22µm. Carrier and preservative free.
Storage
Store at + 4°C. Stable for 12 months. Do Not Freeze this product!
General Notes
For bulk or custom IVD raw material requests, contact us directly.

IVD reagents are supplied in accordance with standard industry lead times of 4-6 weeks. Where products are in stock, dispatch typically occurs within 7-10 business days.
Synonyms
Cell surface glycoprotein MUC18, Cell surface glycoprotein P1H12, MCAM, Melanoma cell adhesion molecule, Melanoma-associated antigen A32, Melanoma-associated antigen MUC18, MUC18, S-endo 1 endothelial-associated antigen
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-CD146 Antibody [B-T46] - BSA and Azide free (A342151)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-CD146 Antibody [B-T46] - BSA and Azide free (A342151)

Proteins predicted to interact with CD146

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
96.1% Relevancy Score
94.1% Relevancy Score
88.9% Relevancy Score
85.2% Relevancy Score
83.4% Relevancy Score
82% Relevancy Score
80.6% Relevancy Score
80.5% Relevancy Score
80.2% Relevancy Score